Fixed-Dose Rifapentine–Isoniazid (1HP) for Tuberculosis Preventive Treatment in Chinese Adults: A Prospective Real-World Safety and Pharmacokinetic Study
- Journal:
- Clinical Infectious Diseases
- Published:
- DOI:
- 10.1093/cid/ciag247
- Affiliations:
- 3
- Authors:
- 9
| Institutions | Authors | Share |
|---|---|---|
| National Clinical Research Center for Infectious Diseases at Shenzhen Third People's Hospital, SUSTech, China | 0.61 | |
| Shenzhen Third People's Hospital, SUSTech, China | 0.39 |